Article
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance
23 Jun 2021
Abstract excerpt
While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow-COVseq-which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
